Hepatitis B surface antigenemia in chronic hemodialysis patients: Effect of hepatitis B immunization

American Journal of Gastroenterology

Volumn 97, Issue 1, 2002, Pages 138-141

  Ly, David ^b   Yee Jr , Hal F ^b   Brezina, Maria ^b   Martin, Paul ^b   Gitnick, Gary ^b   Saab, Sammy ^a  

^a UCLA MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOGLOBULIN M;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY DETECTION; ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; HEMODIALYSIS; HEPATITIS B; HUMAN; IMMUNIZATION; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCREENING TEST; SERODIAGNOSIS;

ADULT; AGED; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HUMANS; KIDNEY FAILURE, CHRONIC; LONG-TERM CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TIME FACTORS; VACCINATION;

EID: 0036140548     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03999-5     Document Type: Article

References (20)

1. Hemodialysis-associated hepatitis in the United States 1974
2. National surveillance of dialysis-associated diseases in the United States
3. Hepatitis B vaccine: Demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States
4. The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men
5. The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies
6. Duration of immunogenicity and efficacy of hepatitis B vaccine in a Yupik Eskimo population
7. Elimination of new chronic hepatitis B virus infections: Results of the Alaska immunization program
8. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group
9. Transient hepatitis B antigenemia in hemodialysis patients following hepatitis B vaccination
10. National surveillance of dialysis-associated diseases in the United States, 1997
11. Prevention Recommmendations for protection against viral hepatitis Recommendations of the Immunization Practices Advisory Committee (ACIP)
12. Hepatitis A and hepatitis B vaccines
13. Transient blood surface antigens of hepatitis B in patients on hemodialysis
14. Vaccine-induced hepatitis B surface antigen positivity in adult hemodialysis patients: Incidental and surveillance data
15. The test for hepatitis B surface antigen is transiently positive after vaccination with recombinant vaccine
16. Response to the hepatitis B virus vaccine in haemodialysis patients: Influence of malnutrition and its importance as a risk factor for morbidity and mortality
17. The use of vaccines in renal failure
18. Absence of hepatitis B surface antigenemia after vaccination
19. Hepatitis B surface antigenemia in blood donors following vaccination
20. Hemodialysis-associated hepatitis B: Revised recommendations for serologic screening